Novo Nordisk shares dropped as low as $46.90 in Thursday’s session, their lowest level since January 2022, following a profit warning.

COPENHAGEN (Reuters) -Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent ...

Novo Nordisk (NVO) downgraded to Hold by HSBC amid growth concerns, GLP-1 market challenges, and revised 2025-2026 earnings ...

European stocks logged their biggest one-day drop in over three months on Friday, at the end of a busy week as investors ...

Just six weeks ago, things seemed to be getting better for Novo Nordisk A/S. Investors were optimistic, and the Danish drugmaker was briefly Europe’s most valuable public company again. Now, the stock ...

European stocks hit a 3-week low on Friday at the end of a busy week as investors worried about the impact of fresh U.S.

SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major ...

But within weeks, Novo Nordisk’s partnership crumbled amid a messy war of words. Novo Nordisk accused Hims & Hers of continuing to deceptively sell large volumes of copycat vers ...

Novo Nordisk has struggled to adapt to very high demand and a market where celebrities are more influential than doctors.

A doctor has issued a warning to people who use weight loss jabs over the 'golden dose'. The use of GLP-1 medication, such as ...

The Danish Meteorological Institute has issued a weather warning for local cloudbursts and thunder across large parts of the country, valid until Friday evening. A low-pressure system is currently ...

Investing.com - Shares of European drugmakers fell on Friday after President Donald Trump issued letters to more than a dozen ...